Analyst Reco. West Pharmaceutical Services, Inc. Sao Paulo

Equities

W2ST34

BRW2STBDR007

Market Closed - Sao Paulo Other stock markets 09:00:05 2024-06-27 EDT			5-day change	1st Jan Change
50.35 ^BRL	+0.30%		+3.60%	+2.65%

06-13	West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	MT
06-04	Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	06-13	MT
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing	05-09	MT
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating	04-26	MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423	04-26	MT
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400	04-25	MT
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating	02-16	MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating	02-16	MT
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	02-16
KeyBanc Adjusts West Pharmaceutical Services Price Target to $470 From $440, Maintains Overweight Rating	02-13	MT
Jefferies Upgrades West Pharmaceutical Services to Buy From Hold, Adjusts Price Target to $536 From $323	02-07	MT
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	02-07
ANALYST RECOMMENDATIONS : Abbvie, Burberry, Chevron, Cisco, M&S...	11-16
Stephens Lowers Price Target on West Pharmaceutical Services to $390 From $420, Maintains Overweight Rating	23-10-27	MT
Deutsche Bank Cuts West Pharmaceutical Services Price Target to $350 From $360, Maintains Hold Rating	23-10-27	MT
Keybanc Adjusts Price Target on West Pharmaceutical Services to $440 From $415, Maintains Overweight Rating	23-08-30	MT
KeyBanc Adjusts West Pharmaceutical Services' Price Target to $415 From $385, Keeps Overweight Rating	23-08-21	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $360 From $290, Maintains Hold Rating	23-07-20	MT
Stephens Adjusts West Pharmaceutical Services' Price Target to $420 From $400, Keeps Overweight Rating	23-07-17	MT
UBS Adjusts Price Target on West Pharmaceutical Services to $400 From $365, Maintains Neutral Rating	23-07-10	MT
BofA Securities Upgrades West Pharmaceutical Services to Buy From Neutral, Raises Price Target to $405 From $390	23-06-16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. West Pharmaceutical Services, Inc. Sao Paulo

Equities

W2ST34

BRW2STBDR007

Analyst Reco.

Filters